Minneapolis

Minneapolis and Saint Paul form the global capital of medical device innovation, anchored by the University of Minnesota’s biomedical research enterprise and the headquarters of Medtronic, Boston Scientific, and hundreds of medtech companies. Melan works with medical device and health-tech teams across the Twin Cities to structure research partnerships that advance the standard of care.


The Twin Cities Research Partnership Landscape

The University of Minnesota is a top-20 public research university with over $1.2 billion in annual research expenditures. Its strengths span biomedical engineering, transplant surgery, cardiology, materials science, and food science — disciplines that intersect directly with the region’s medtech and agribusiness industries. The Mayo Clinic, based 90 minutes south in Rochester, adds a world-class clinical research infrastructure that Twin Cities companies regularly access for clinical trials and translational research.

The medtech corporate concentration is unmatched. Medtronic (the world’s largest medical device company), Boston Scientific, Abbott (cardiac and diabetes devices), Smiths Medical, and St. Jude Medical (now Abbott) all have headquarters or major R&D operations in the region. 3M adds materials science and surface technology R&D. The Earl E. Bakken Medical Devices Center at UMN directly bridges academic research and medtech commercialization.

The Twin Cities partnership landscape is defined by the convergence of materials science, electronics miniaturization, and clinical need — a combination that requires structured collaboration between academic researchers and medical device engineers.


What Melan Does for Teams in the Twin Cities

For medical device and health-tech R&D teams: We identify academic partners across UMN and Mayo Clinic aligned with your device development priorities — from UMN’s Institute for Engineering in Medicine to Mayo’s clinical trial infrastructure. We structure sponsored research, material licensing, and clinical validation partnerships.

For UMN and Mayo researchers: We help TTOs and principal investigators find corporate partners who can commercialize their medical device and therapeutic discoveries, navigate the FDA regulatory pathway requirements in partnership agreements, and structure licensing deals that reflect clinical-stage value.

For agtech and food science companies: UMN’s College of Food, Agricultural and Natural Resource Sciences and its partnership with General Mills, Cargill, and other agribusiness giants create unique research collaboration opportunities. Melan structures these partnerships to bridge agricultural research with commercial application.


FAQ

How does Melan help companies partner with the University of Minnesota?

We map UMN’s research centers — from the Earl E. Bakken Medical Devices Center to the Minnesota Supercomputing Institute — to identify the labs and PIs aligned with your R&D priorities, then approach UMN’s Technology Commercialization office with a structured framework.

What makes the Twin Cities unique for research partnerships?

The Twin Cities combine the world’s highest concentration of medical device R&D headquarters with a top-20 research university and proximity to Mayo Clinic. No other region offers this density of medtech-academic partnership opportunity.

Does Melan work with Minnesota medtech and agtech companies?

Yes. We work with device companies, 3M, and agribusiness firms to structure research partnerships across UMN’s biomedical engineering, materials science, and food science programs.

How do I start a research partnership in the Twin Cities?

Contact Melan at themelan.com/contact-us. We discuss your R&D priorities and map the Twin Cities research ecosystem to identify the right collaborators.


Ready to form a research partnership in Minneapolis or Saint Paul?

Melan helps medtech, health-tech, and agtech R&D teams across the Twin Cities structure successful research collaborations.

Speak to Our Team →

Have a unique project in mind? Let's talk.

Melan connects corporations, researchers, labs, and foundations with the technology partnerships they need to move further, faster.